Target intelligence / Profile preview

Th2 cell cytokine

Molecular classification
Cytokine (for each component molecule), Other (as a collective group)
01

Overview

Th2 cell cytokines are a group of signaling proteins secreted by T helper 2 cells (a CD4+ T cell subset) that orchestrate the antibody-mediated (humoral) immune response, particularly against extracellular pathogens and allergens[1][5]. The main Th2 cytokines include interleukin-4, which drives B cell maturation and IgE class switching; interleukin-5, which promotes eosinophil growth and activation; and interleukin-13, which supports mucus production and tissue remodeling[1][7][5]. These cytokines are involved in important physiological processes like tissue repair but also contribute to pathological states such as allergies, asthma, fibrosis, and certain autoimmune diseases. Therapeutic strategies for related diseases involve targeting specific cytokines and their receptors, not the collective group. In summary, "Th2 cell cytokines" is a non-specific term denoting a family of cytokines, not a singular molecular entity, and is *not* itself a canonical target for drug development[2][5].

Other names
Type 2 cytokinesTh2 cytokinesTh2-associated cytokines
02

Mechanism of action

Neutralization/blockade of cytokine signaling (monoclonal antibodies against IL-4, IL-5, IL-13 or their receptors) Inhibition of downstream inflammatory pathways (e.g., leukotriene synthesis or mast cell degranulation) Suppression of Th2-mediated immune responses

03

Biological functions

Immune response (humoral)Activation of B cells (antibody production)Eosinophil recruitment/activationPromotion of IgE class switchingRegulation of macrophage function (inhibition of some functions, activation of others)Tissue repair and remodelingAllergic inflammation and response
04

Disease associations

Allergy (e.g., asthma, allergic rhinitis, atopic dermatitis)Autoimmune diseases (e.g., systemic lupus erythematosus, systemic sclerosis)Eosinophilic disordersFibrosis (chronic tissue repair leading to pathological fibrosis)Infection (host defense against extracellular parasites, helminths, some bacteria)Other inflammatory diseases
05

Safety considerations

Risk of immunosuppression (increased susceptibility to infection)Possible imbalance toward Th1/Th17 responsesAdverse effects relating to allergy or autoimmunity (paradoxical reactions)
06

Interacting drugs

Anti-IL-5: mepolizumab, benralizumab, reslizumab

4 more in the full profile.

07

Biomarkers

Serum or tissue levels of IL-4, IL-5, IL-13 (indicative of Th2 activity)Eosinophil countIgE levels (reflecting class-switching)

Beyond the preview

Go deeper on Th2 cell cytokine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Th2 cell cytokine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call